As shelf-stable microarray patch (MAP) platforms move through development and clinical work, a ‘packaging first’ mentality is needed for industry-wide adoption.
BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...
Vaxxas has been awarded a tender by the European Health and Digital Executive Agency to help develop next-generation ...
A Brisbane-based biotechnology company behind a needle-free vaccine patch has warned it could take its technology offshore after securing a multimillion-dollar funding boost from European authorities, ...
This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...
Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...
Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyltm Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2026 Earnings Call Transcript February 2, 2026 Twist Bioscience Corporation misses on earnings expectations. Reported EPS is $-0.49946 EPS, expectations ...
Many in Ukraine assume that the alerts are automated. A rare look inside an emergency-response center reveals the specialists ...
This is read by an automated voice. Please report any issues or inconsistencies here. The White House’s new TrumpRx platform launched Thursday, pledging dramatic prescription label price cuts for ...
Right now, many companies are worried about how to get more employees to use AI. After all, the promise of AI reducing the burden of some work—drafting routine documents, summarizing information, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results